3H-PGE2
Hot Ligand Values Explained
- Hot Ligand ID - A unique identifier for the hot ligand
- Ligand Name - Unique name of the hot ligand
- PubMed Compound ID - Unique Compound ID in PubMed datbase
Hot Ligand | 95 |
---|---|
Ligand Name | 3H-PGE2 |
PubMed Compound ID | 5280360 |
Structure | |
Molecular Formula | C20H32O5 |
Molecular Weight | 352.5 |
SMILES | CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O |
Synonyms | Prostaglandin E2 Dinoprostone 363-24-6 PGE2 Prostin E2 Prepidil Cervidil Minprostin E2 Propess Minprositin E2 Dinoproston Dinoprostonum Dinoprostona Cerviprost Enzaprost E PGE2alpha (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Cerviprime Prostenone U-12062 Prostaglandin E2alpha (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid U 12062 K7Q1JQR04M NSC-165560 NSC-196514 Prostaglandin E(2) DTXSID4022947 CHEBI:15551 (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate Dinoprostone beta-Cyclodextrin Clathrate U-12,062 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- DTXCID002947 (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)- Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo- PGE2 alpha Prostaglandin E2 alpha Gel, Prepidil E2, Prostaglandin (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid alpha, PGE2 E2alpha, Prostaglandin alpha, Prostaglandin E2 E2 alpha, Prostaglandin 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]- (E,Z)-(1R,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid (Z)-7-((1R,2R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid RefChem:56458 PGE(2) G02AD02 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid; Prostin E2 (Z)-7-((1R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid 206-656-6 (15S)-Prostaglandin E2 Prostarmon E l-Prostaglandin E2 Glandin l-PGE2 MFCD00077861 Prostaglandin E NSC 165560 [3H]PGE2 [3H]prostaglandin E2 (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid Prostaglandin E2 (GMP) CHEMBL548 NSC 196514 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l- NCGC00092361-05 (-)-Prostaglandin E2 Prostaglandin E2.alpha. (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid Dinoprostonum [INN-Latin] 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid Dinoprostona [INN-Spanish] 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid Prostarmon E2 Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)- Cervidil (TN) Prepidil (TN) CAS-363-24-6 Dinoprostone Prostaglandin E2 U,062 Prostin E2 (TN) PGE2-[3,3,4,4-d4] SR-05000001459 EINECS 206-656-6 UNII-K7Q1JQR04M Dinoprostone (JAN/USP/INN) (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid BML1-F07 Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo- Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)- Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)- [3H]dinoprostone prosta-glandin e2 NCGC00092361-06 (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid Dinoprostone; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; PGE2 Prestwick_793 (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid [3H]prostin E2 BMS-279654 & PGE2 Dinoprostone [USAN:USP:INN:BAN:JAN] Prostaglandin E2;PGE2 (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic DINOPROSTONE [INN] DINOPROSTONE [JAN] DINOPROSTONE [USAN] (+/-)-Prostaglandin E2 DINOPROSTONE [VANDF] SCHEMBL25533 BSPBio_001490 DINOPROSTONE [MART.] Prostaglandin E2 (Standard) DINOPROSTONE [USP-RS] DINOPROSTONE [WHO-DD] Prostaglandin E2 (Cervidil)? PROSTAGLANDIN E2 [MI] GTPL1883 GTPL1916 orb1302168 [3H]-PGE2 BDBM35847 DTXSID00859353 DINOPROSTONE [ORANGE BOOK] HMS1361K12 HMS1791K12 HMS1989K12 HMS2089D17 HMS3268J12 HMS3402K12 HMS3413C20 HMS3648F07 HMS3677C20 DINOPROSTONE [EP MONOGRAPH] DINOPROSTONE [USP IMPURITY] EX-A1773 MSK15026 P2E DINOPROSTONE [USP MONOGRAPH] Tox21_111196 HB3460 LMFA03010003 NSC165560 NSC196514 s3003 (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid AKOS015920228 Tox21_111196_1 AC-6098 CCG-208092 CCG-208256 CS-6932 DB00917 FD31827 HY-101952G HY-101952R IDI1_033960 SMP2_000056 NCGC00092361-01 NCGC00092361-02 NCGC00092361-03 NCGC00092361-04 AS-71847 SY057971 Dinoprostone 100 microg/mL in Acetonitrile HY-101952 ALPROSTADIL IMPURITY G [EP IMPURITY] CS-0626105 NS00009026 P1884 C00584 D00079 Prostaglandin E2, >=93% (HPLC), synthetic 363P246 EN300-22411484 Q416554 SR-01000946417 SR-01000946417-1 SR-05000001459-1 SR-05000001459-3 SR-05000001459-4 BRD-K26521938-001-04-9 BRD-K26521938-001-07-2 BRD-K26521938-001-09-8 05D31BD5-818B-4A92-8CFC-BEC19926A5B3 Dinoprostone, European Pharmacopoeia (EP) Reference Standard (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate Dinoprostone, United States Pharmacopeia (USP) Reference Standard (5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid 5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxo-rosta-5,13-dien-1-oic acid Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture (5Z,11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Prostaglandin E2, gamma-irradiated, powder, BioXtra, suitable for cell culture 22230-04-2 |
Created At | Jan 14, 2025 10:59 am |
Updated At | Jan 14, 2025 10:59 am |